ORGO Bull Call Spread Strategy
ORGO (Organogenesis Holdings Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cytokines. NuShield provides a wound covering incorporating both amnion and chorion membranes to maintain a spongy intermediate layer. PuraPly acts as an antimicrobial barrier, allowing for flexibility and effective fluid drainage.
ORGO (Organogenesis Holdings Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $312.7M, a beta of 1.33 versus the broader market, a 52-week range of 2.04-7.077, average daily share volume of 1.5M, a public-listing history dating back to 2017, approximately 869 full-time employees. These structural characteristics shape how ORGO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.33 indicates ORGO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bull call spread on ORGO?
A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width.
Current ORGO snapshot
As of June 26, 2026, spot at $2.40, ATM IV 24.90%, IV rank 1.43%, expected move 7.14%. The bull call spread on ORGO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 21-day expiry.
Why this bull call spread structure on ORGO specifically: ORGO IV at 24.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a ORGO bull call spread, with a market-implied 1-standard-deviation move of approximately 7.14% (roughly $0.17 on the underlying). The 21-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ORGO expiries trade a higher absolute premium for lower per-day decay. Position sizing on ORGO should anchor to the underlying notional of $2.40 per share and to the trader's directional view on ORGO stock.
ORGO bull call spread setup
The ORGO bull call spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ORGO near $2.40, the first option leg uses a $2.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ORGO chain at a 21-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ORGO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $2.40 | N/A |
| Sell 1 | Call | $2.52 | N/A |
ORGO bull call spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit.
ORGO bull call spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bull call spread on ORGO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bull call spread on ORGO
Bull call spreads on ORGO reduce the cost of a bullish ORGO stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
ORGO thesis for this bull call spread
The market-implied 1-standard-deviation range for ORGO extends from approximately $2.23 on the downside to $2.57 on the upside. A ORGO bull call spread caps both the risk and the reward of a bullish position; relative to an outright long call on ORGO, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current ORGO IV rank near 1.43% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ORGO at 24.90%. As a Healthcare name, ORGO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ORGO-specific events.
ORGO bull call spread positions are structurally moderately bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ORGO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ORGO alongside the broader basket even when ORGO-specific fundamentals are unchanged. Long-premium structures like a bull call spread on ORGO are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ORGO chain quotes before placing a trade.
Frequently asked questions
- What is a bull call spread on ORGO?
- A bull call spread on ORGO is the bull call spread strategy applied to ORGO (stock). The strategy is structurally moderately bullish: A bull call spread buys an at-the-money call and sells an out-of-the-money call at a higher strike for defined risk and defined reward bounded by the strike width. With ORGO stock trading near $2.40, the strikes shown on this page are snapped to the nearest listed ORGO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ORGO bull call spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-call strike plus net debit. For the ORGO bull call spread priced from the end-of-day chain at a 30-day expiry (ATM IV 24.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ORGO bull call spread?
- The breakeven for the ORGO bull call spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ORGO market-implied 1-standard-deviation expected move is approximately 7.14%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bull call spread on ORGO?
- Bull call spreads on ORGO reduce the cost of a bullish ORGO stock position by selling a higher-strike call; suited to moderate-move theses where price reaches but does not vastly exceed the short strike.
- How does current ORGO implied volatility affect this bull call spread?
- ORGO ATM IV is at 24.90% with IV rank near 1.43%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.